drugset / Trial / NCT01397240

The Safety and Efficacy of Albis®: The Prevention of Aspirin-induced Gastrointestinal Ulcers in Patients

NCT01397240 ↗

Phase 4 Unknown 80 enrolled Daewoong Pharmaceutical Co. LTD.
RandomizedParallel-groupTriple-blindPrevention

Summary

The purpose of this study is to research the safety and efficacy of Albis® for the prevention of aspirin-induced gastrointestinal ulcers in patients taking low-dose aspirin.

Timeline

Start
2011-07
Primary completion
2012-01
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Albis Tab Unknown 2 unknown —

Indications

No indication recorded.